The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
Neuromuscular junction ultrastructure in rat forelimb digit extensor muscle was sequentially and quantitatively investigated in experimental autoimmune myasthenia gravis (EAMG). Experimental animals received a single dose of highly purified eel-electroplax acetylcholine receptor protein plus complete Freund's adjuvant and B. pertussis organisms. During the first 7 days (latent period) after immunization the experimental end plates remained normal. Between day 7 and 11 (acute phase) mononuclear cells infiltrated those regions of muscle where the end plates were located and the was sudden degeneration of the postsynaptic regions with splitting  away of the abnormal junctional folds from the underlying muscle fibers. Macrophages entered the gaps arising between the muscle fibers and the separating postsynaptic folds and removed the degenerating folds by phagocytosis. The nerve terminals were displaced from their usual location but maintained their structural integrity. After day 11 (chronic phase) the inflammatory reaction subsided and the nerve terminals returned to the highly simplified postsynaptic regions. Subsequently the postsynaptic folds were reconstituted and again they degenerated. The degeneration involved  especially the tips of the folds where acetylcholine receptor sites are concentrated. Immature junctions with poorly differentiated postsynaptic regions and nerve sprouts near end plates were also observed. In two animals that relapsed on day 27 and 33, respectively, degeneration of the postsynaptic folds was more intense than in the remaining animals that had not relapsed during the chronic phase. Morphometric analysis of the end plates demonstrated significant decreases in the postsynaptic membrane length, in the postsynaptic membrane density  and in the postsynaptic to presynaptic membrane length ratio in chronic EAMG. In addition, the concentration of synaptic vesicles in the nerve terminals was increased in acute and chronic EAMG while the nerve terminal area was decreased in acute EAMG. The alterations in the nerve terminal may be secondary to the postsynaptic changes. The postsynaptic region is the primary target of the autoimmune reaction in EAMG and the ultrastructural and morphometric abnormalities of the end plate in the chronic phase of the syndrome closely resemble those which have been observed in human myasthenia gravis.
D000818:Animals; D001327:Autoimmune Diseases / Q000473:pathology*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004195:Disease Models, Animal; D005260:Female; D005620:Freund's Adjuvant; D009045:Motor Endplate / Q000187:drug effects / Q000648:ultrastructure*; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D009388:Neostigmine / Q000009:adverse effects; D009411:Nerve Endings / Q000648:ultrastructure; D009419:Nerve Tissue Proteins / Q000008:administration & dosage; D009469:Neuromuscular Junction / Q000648:ultrastructure*; D051381:Rats; D013570:Synaptic Membranes / Q000648:ultrastructure; D014917:Whooping Cough / Q000382:microbiology
D002800:Cholinesterase Inhibitors; D009419:Nerve Tissue Proteins; D009388:Neostigmine; D005620:Freund's Adjuvant